RSIP Vision

RSIP Vision

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $8M

Overview

RSIP Vision is a specialized AI software and R&D services company focused exclusively on medical image analysis. It partners with medical device manufacturers to integrate field-tested, clinically proven AI capabilities into their products, accelerating development from concept to regulatory approval. The company has over two decades of collective experience, with applications in cardiology, orthopedics, surgery, and more, and is trusted by industry leaders. Its business model is based on providing custom development and proprietary software modules, positioning it as an enabling technology partner in the digital health ecosystem.

CardiologyOrthopedicsGastroenterologyPulmonologySurgeryENTUrologyOphthalmology

Technology Platform

A deep learning and computer vision platform specialized for medical image analysis across multiple modalities (CT, MRI, ultrasound, endoscopy, etc.). Capabilities include segmentation, registration, detection, classification, and real-time surgical video analysis, developed with clinical robustness and regulatory pathways in mind.

Funding History

1
Total raised:$8M
Series A$8M

Opportunities

The rapid adoption of AI in medical imaging and surgical robotics presents a massive growth opportunity.
As medical device companies race to integrate AI, RSIP Vision's role as a specialized, experienced partner for developing and integrating robust, clinically validated algorithms is increasingly valuable.
Expansion into adjacent areas like AI-powered surgical workflow optimization and real-time interventional guidance offers further growth avenues.

Risk Factors

Key risks include dependence on a limited number of large medical device clients, intense competition from both specialized AI startups and large tech firms, and the inherent complexity and regulatory co-dependency of medical AI projects.
Geopolitical factors related to its primary R&D location in Jerusalem also pose a potential operational risk.

Competitive Landscape

RSIP Vision competes with other specialized medical AI software vendors (e.g., Arterys, Aidoc), internal R&D teams at large medtech companies, and general-purpose AI/cloud platforms from tech giants (Google, NVIDIA). Its differentiation lies in its deep, field-tested expertise across multiple clinical domains, a focus on integration into regulated medical devices, and a proven track record of taking projects from concept to clinical use.